BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Countries North America

CordenPharma Announces €900 Million Investment to Expand Peptide Manufacturing Capabilities in US and Europe

CordenPharma has announced its largest strategic investment to date with a committed spend of ~€900m over the next 3 years to grow its Peptide technol...

July 17, 2024 | News

Jubilant Radiopharma Invests $50 Million to Expand PET Radiopharmaceutical Manufacturing Facilities in the U.S.

Jubilant Radiopharma’s Radiopharmacies division is excited to announce an investment of $50 million (USD) to expand its PET radiopharmaceutical manuf...

June 25, 2024 | News

Wisp Expands Telehealth Services with New Fertility Vertical to Support Women Trying to Conceive

Wisp, the fastest growing sexual and reproductive telehealth provider in the U.S, today announced a new fertility vertical consisting of several products a...

June 13, 2024 | News

Sartorius Opens New $100 Million Bioanalytics Center in Ann Arbor

The life science group Sartorius opened its new Center of Excellence for bioanalytics in Ann Arbor, Michigan, two years after breaking ground in ...

June 06, 2024 | News

Enzene Biosciences Launches New Drug Discovery Division, Expands CDMO Services Amid Growing Biotech Demands

Enzene Biosciences, a leading global CDMO known for its flagship fully-connected continuous manufacturing platform (EnzeneXTM) today announces the launch o...

May 30, 2024 | News

Providence Therapeutic Holdings and Ontario Institute for Cancer Research Announce Landmark Collaboration for mRNA Drug Discovery and Development

Providence Therapeutic Holdings Inc. ("Providence"), a messenger RNA (mRNA) and lipid nanoparticle platform company engaged in the development of vaccines ...

May 24, 2024 | News

CAS Unveils CAS BioFinder Discovery Platform™ to Transform Drug Discovery Process

CAS, a division of the American Chemical Society specializing in scientific knowledge management, announced the launch of the CAS BioFinder Discovery Platf...

May 22, 2024 | News

Allucent Secures $25.5 Million Award for Decentralized COVID-19 Trial

Allucent, a global mid-sized clinical research organization (CRO), announced that it received a project award valued at $25.5 million...

May 16, 2024 | News

Cellipont Bioservices Partners with Adva Biotechnology to Launch Innovative ADVA X3® Platform

Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), and Adva Biotechnology, an Israel-based...

May 08, 2024 | News

Takara Bio USA Introduces Innovative Lenti-X Transduction Sponge for Gene Delivery

Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., announced the launch of the Lenti-X™ Transduction Sponge, a first-to-market disso...

May 07, 2024 | News

Latus Bio Launches with $54 Million Series A to Advance CNS Gene Therapy

Latus Bio, a biotechnology company developing novel gene therapy candidates for disorders of the central nervous system (CNS), today announced its launch a...

May 03, 2024 | News

ImmunityBio and Serum Institute of India Secure Global BCG Supply Agreement for Cancer Treatment

Collaboration will result in BCG manufacture at large scale for use in combination with ANKTIVA®, ImmunityBio’s recently approved treatme...

May 03, 2024 | News

GE HealthCare Gains FDA 510(k) Clearance for Advanced Portrait VSM Vital Signs Monitor

GE HealthCare announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its Portrait VSM vital signs monitor...

April 30, 2024 | News

Pfizer and Genmab's TIVDAK Wins FDA Full Approval for Cervical Cancer After Outperforming Chemotherapy in Key Trial

TIVDAK is the first antibody-drug conjugate (ADC) to have positive overall survival data for patients with previously treated recurrent or metastat...

April 30, 2024 | News

Stay Connected